WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H540276
CAS#: 115144-35-9
Description: D-Luciferin potassium is heterocyclic light-emitting compound and natural ligand for luciferase used to detect cell activity. It requires ATP for its reaction, emitting a greenish-yellow luminescence at a peak wavelength of approximately 530 nm. The salt form of luciferin dissolves in water or other typical buffers.
Hodoodo Cat#: H540276
Name: D-Luciferin potassium
CAS#: 115144-35-9
Chemical Formula: C11H7KN2O3S2
Exact Mass: 0.00
Molecular Weight: 318.406
Elemental Analysis: C, 41.49; H, 2.22; K, 12.28; N, 8.80; O, 15.07; S, 20.14
Synonym: D-Luciferin potassium
IUPAC/Chemical Name: potassium (S,Z)-2-(6-oxobenzo[d]thiazol-2(6H)-ylidene)thiazolidine-4-carboxylate
InChi Key: PWQWXGFOCJCDIF-SREJTOIWSA-M
InChi Code: InChI=1S/C11H8N2O3S2.K/c14-5-1-2-6-8(3-5)18-10(12-6)9-13-7(4-17-9)11(15)16;/h1-3,7,13H,4H2,(H,15,16);/q;+1/p-1/b10-9-;/t7-;/m1./s1
SMILES Code: O=C([C@@H]1N/C(SC1)=C(N=C2C=C3)/SC2=CC3=O)[O-].[K+]
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 318.41 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Pavlov AM, Sukhorukov GB, Gould DJ. Lessons in microcapsule assembly from imaging delivery of a bioluminescent enzyme. Biomacromolecules. 2013 Mar 11;14(3):608-12. doi: 10.1021/bm3019054. Epub 2013 Mar 1. PubMed PMID: 23398503.
2: Henriques C, Henriques-Pons A, Meuser-Batista M, Ribeiro AS, de Souza W. In vivo imaging of mice infected with bioluminescent Trypanosoma cruzi unveils novel sites of infection. Parasit Vectors. 2014 Mar 3;7:89. doi: 10.1186/1756-3305-7-89. PubMed PMID: 24589192; PubMed Central PMCID: PMC3973021.